FDA Inspection 1026792 — Frank C. Hampel, M.D
The FDA completed an inspection of Frank C. Hampel, M.D on Sep 14, 2017 in New Braunfels, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 14, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- New Braunfels, TX (United States)
Additional details
Clinical Investigator (CI)